SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

Caris Life Sciences Inc.

Caris Life Sciences is trending as the market digests strong preliminary 2025 revenue guidance and its first quarter of positive adjusted EBITDA and cash flow from operations, fueling debate among investors over whether this AI-powered precision oncology firm is an undervalued gem or facing headwinds from valuation concerns and an upcoming IPO lockup expiration.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is actively trending as its board reconsiders a sweetened hostile takeover bid from Paramount Skydance, fueled by Netflix's temporary waiver and intensified DOJ scrutiny of Netflix's original offer. The community is debating which path offers better shareholder value and a clearer regulatory approval amidst the fierce media industry consolidation.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is drawing significant investor attention due to recent conservative 2026 revenue guidance and uncertainty surrounding DefenCath's post-TDAPA reimbursement, fueling widespread frustration despite a new $75 million share repurchase program. The community is actively discussing potential legislative fixes and upcoming pipeline catalysts like Rezzayo's Phase 3 data, while scrutinizing management's actions amid the stock's pronounced decline.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is a top trending fintech following a robust earnings beat showcasing accelerated customer growth and monetization across Latin America. Community discussion highlights its new conditional U.S. bank charter approval and high-profile partnerships as key catalysts for global expansion, despite some investor frustration regarding stock performance amidst strong fundamentals.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending following its recent listing on Robinhood, with fervent community discussion centered on its potential as Coinbase's premier perpetual decentralized exchange on the #base app. While supporters highlight its significant undervaluation compared to rivals and strong platform backing, a vocal segment raises concerns about its past performance, tokenomics, and leadership, labeling it a 'scam' or 'rug pull'.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a high-stakes bidding war for Warner Bros. Discovery, intensified by a widening DOJ antitrust probe and political threats; the community is actively debating whether walking away with a breakup fee or proceeding with the acquisition would be a better outcome for the streaming giant.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BridgeBio Pharma is currently trending due to a series of overwhelmingly positive Phase 3 clinical trial results, including a breakthrough oral treatment for achondroplasia that is seen as a major competitive advancement. This strong pipeline performance, coupled with robust Attruby sales and significant analyst upgrades, has ignited community excitement about the company's rapid evolution into a leading multi-product rare disease biotech.

Aztec is the leading privacy-first Layer 2 on Ethereum, empowering developers to build applications that protect user privacy. Backed by a $100M Series B led by a16z, Aztec is led by a team of world-class cryptographers who invented the standard for trustless client-side proving—making privacy-preserving apps possible.  In a landscape where speed and novelty rarely translate into durable moats, Aztec’s sustained traction, deep institutional adoption, and growing ecosystem around privacy-preserving cryptography validate that its work has broken through the “flock,” proving privacy isn’t a feature race but a foundational technology trusted to underpin real, long-term financial infrastructure.   1. Pioneers of Privacy in Web3 Aztec's team developed PLONK in 2019, a SNARK-based proving system that is computationally inexpensive and only requires one universal trusted setup. PLONK was a big breakthrough, not just for Aztec, but for the wider blockchain community. Today, PLONK has been implemented and extended by teams like zkSync, Polygon, Mina, and more. There is even an entire category of proving systems called PLONKish that all derive from the original 2019 paper. The foundational cryptography behind modern privacy infrastructure was built by the Aztec team.  2. Noir: The Universal ZK Programming Language The Aztec Labs team developed Noir, a Rust-like programming language for writing zero-knowledge circuits that make privacy technology accessible to mainstream developers. With 500+ GitHub projects and recognition as Electric Capital’s top 5 fastest-growing developer ecosystems, Noir is becoming the standard for zk development and is used today by projects across Solana, Stellar, Starkware, and World.   3. Drawing Institutional Attention Across Tradfi, Stablecoins, and Real-World Assets  JP Morgan was an early institutional tester of Aztec’s technology, with its Quorum blockchain team actively evaluating and experimenting with Aztec as part of its effort to industrialize privacy-preserving cryptography for regulated financial use cases back in 2019.  The Taurus confidential token standard was built on Aztec’s technology and adopted by a leading institutional infrastructure provider. This proves that Aztec is not just a research project, but a credible, production-ready platform and a foundational player in the privacy-preserving financial infrastructure stack.

Aztec

Aztec is trending after its Token Generation Event and rare simultaneous listings on major exchanges like Coinbase and Binance, which also launched 5x Perpetuals. The crypto community highlights its utility as an Ethereum privacy Layer 2 solution with Zero Knowledge Proofs, generating significant buzz around its potential for institutional adoption.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as recent preliminary benchmarks for its Gemini-II Compute-in-Memory chip claim competitive multimodal LLM inference at the edge with significantly lower power consumption than rivals. This news is sparking intense debate among investors, with bulls highlighting the chip's potential for defense and drone applications and institutional interest, while critics vehemently allege fraudulent performance claims and an ongoing class-action investigation regarding misleading statements.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is trending strongly after delivering robust earnings and optimistic guidance, which has spurred significant analyst upgrades and a highly bullish sentiment within the community. As a crucial semiconductor equipment supplier, the company is seen as a primary beneficiary of accelerating AI and memory chip demand, driving increased wafer fabrication equipment spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


BYI
Bally Technologies, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest BYI News

BYIBally Technologies, Inc.